Concepedia

A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment

Kaori Yoshimura, Yuko Tamano, Hiep Nguyen Canh, Li Zihan, Dong Le Thanh, Yasunori Sato, Takeshi Terashima, Shinji Shimoda, Kenichi Harada

Medical Molecular Morphology · 2023 · 10 citations · 22 references

DOI

Concepts

References

22

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Eléonora De Martin, Jean‐Marie Michot, Barbara Papouin et al. · Journal of Hepatology · 2018 · 532 citations

, , +16

Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.

Ryotaro Yoshida, Jirô Imanishi, T Oku et al. · Proceedings of the National Academy of Sciences · 1981 · 295 citations · Full text

, , +9

Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury

Yoh Zen, Matthew M. Yeh · Modern Pathology · 2018 · 288 citations · Full text

, , +17

Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population

Minoru Nakamura, Nao Nishida, Minae Kawashima et al. · The American Journal of Human Genetics · 2012 · 271 citations · Full text

, , +12

Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer

Hisato Kawakami, Junko Tanizaki, Kaoru Tanaka et al. · Investigational New Drugs · 2017 · 170 citations

, , +16